• Lower Respiratory Tract Infections.
• Pelvic Inflammatory Disease.
• Post-partum Endometritis.
• Gynecological Infections.
• Appendicitis/ Peritonitis.
• Skin And Structure Infections.
• Septicemia.
• Febrile Neutropenia.

Indications:

• Highly active against B-lactamase producing resistant microorganisms.
• More effective than ticarcillin/clavulanate in patients with community-acquired lower respiratory tract infections¹.
• Shows higer bacteriological success when compared to imipenem/cilastatin².
• Excellent safety and tolerability profile³.